Home › Cardiovascular Disease › NCT00378924

Cardiology Biobank Registry

Who can join

Ages 20 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

1. All hospital and clinic participants aged 18 years and older
2. Participants with and without active or presumed cardiovascular disease including but not limited to:

   1. Coronary Artery Disease
   2. Heart Failure and Cardiomyopathies
   3. Peripheral Vascular Disease
   4. Valve disease
   5. Adult Congenital Heart disease
   6. Electrophysiological Disorders
3. Any individual aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.

Exclusion Criteria:

1. Significant Documented Anemia (Hemoglobin \<8 g/dL)
2. Blood transfusions within past 3 weeks
3. Enrollment against doctor recommendation
4. Participant not able to provide consent including but not limited to:

   1. Intubated and critically unwell participants
   2. Dementia
   3. Alzheimer's disease
   4. Moderate to severe alcohol or drug abuse
   5. Against religious beliefs (e.g. Jehovah's witness)

About the study

In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers.

Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively.

By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Sponsor: Emory University · Participants: 12,000 · Started: 2003-12

Contact the study team

• Ayman J Tahhan, MD · Phone: 404 712 0168
• Salman Sher, MD · Phone: 404 412 0170

Official record on ClinicalTrials.gov — NCT00378924

Locations in the U.S.

Conditions

• Cardiovascular Disease

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.